Showing results (611-620 of 645) with videos related to

Sort By:
Pageof 65
American Journal of Hematology|July 29, 2021
Multi-center analysis of practice patterns and outcomes of younger and older patients with mantle cell lymphoma in the rituximab eraReem Karmali, Jeffrey M Switchenko, Subir Goyal, et al.
European Journal of Haematology|May 11, 2021
Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survivalKrithika Shanmugasundaram, Subir Goyal, Jeffery Switchenko, et al.
Annals of Surgery|December 18, 2024
Neoadjuvant Pembrolizumab in Stage I-III Deficient Mismatch Repair Colon Cancer: A Clinical TrialIsmail Gögenur, Tobias Freyberg Justesen, Line Schmidt Tarpgaard, et al.
Nature Cancer|March 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphomaFelix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, et al.
Nature Communications|November 5, 2025
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphomaSunandini Sharma, Roshia Ali, Alyssa Bouska, et al.
Perioperative Medicine (London, England)|August 8, 2022
The Perioperative Quality Improvement Programme (PQIP patient study): protocol for a UK multicentre, prospective cohort study to measure quality of care and outcomes after major surgeryS Ramani Moonesinghe, Dermot McGuckin, Peter Martin, et al.
The New England Journal of Medicine|November 26, 2024
Aggressive Lymphoma after CD19 CAR T-Cell TherapyGuido Kobbe, Monika Brüggemann, Ben-Niklas Baermann, et al.
Blood|April 14, 2026
Diagnosis-to-Treatment Interval Is Associated With Outcomes in Follicular Lymphoma Treated with ImmunochemotherapyProkop Vodička, Tarec C El-Galaly, Vit Prochazka, et al.
Geburtshilfe Und Frauenheilkunde|April 19, 2021
Diagnosis and Treatment of Endometriosis. Guideline of the DGGG, SGGG and OEGGG (S2k Level, AWMF Registry Number 015/045, August 2020)Stefanie Burghaus, Sebastian D Schäfer, Matthias W Beckmann, et al.
Blood Advances|February 23, 2022
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphomaJuan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, et al.
Pageof 65